Patrick Spence, PhD
Dr. Spence is responsible for chemistry and analytical sciences, overseeing drug substance and analytical development as well as other chemistry, manufacturing and control activities.
Prior to joining IPM in 2014, Dr. Spence spent over 16 years in the pharmaceutical industry in leadership positions of increasing responsibility. As a consultant for Validant, he directed a group of consultants focused on data integrity, pre-approval inspection preparation and other quality-oriented activities. Previously, Dr. Spence oversaw analytical development and quality control at Nektar Therapeutics, including a group in Hyderabad, India. In that role, he prepared documentation for and presented to health authorities on analytical topics. Prior to that, he led analytical development groups focused on dosage form characterization and analysis at Novartis and Schering-Plough. He began his career as a synthetic organic chemist at Bayer.
Dr. Spence received his bachelor’s degree in chemistry/physics from the University of Maine at Farmington and his MSc and PhD in organic chemistry from the University of Illinois at Urbana-Champaign.